Skip to content
Disclosery

EXANE DERIVATIVES: NSA position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on NSA, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 2,989 NSA shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 2,989 shares
    Change vs previous 13F +10 shares

    0.09% of the 13F portfolio, value $149,629.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 2,979 shares
    Change vs previous 13F +94 shares

    0.05% of the 13F portfolio, value $186,951.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 2,885 shares
    Change vs previous 13F -42 shares

    0.05% of the 13F portfolio, value $199,635.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 2,927 shares
    Change vs previous 13F -67 shares

    0.04% of the 13F portfolio, value $154,511.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 2,994 shares
    Change vs previous 13F -376 shares

    0.04% of the 13F portfolio, value $157,840.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 3,370 shares
    Change vs previous 13F -328 shares

    0.04% of the 13F portfolio, value $134,558.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 3,698 shares
    Change vs previous 13F -259 shares

    0.04% of the 13F portfolio, value $133,233.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 3,957 shares
    Change vs previous 13F not available

    0.04% of the 13F portfolio, value $129,426.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).